D.M. Burger

Evidence of the Existence of a New Circulating Recombinant Form of HIV Type 1 Subtype A/J in Cameroon

Has the era of individualised medicine arrived for antifungals? A review of antifungal pharmacogenomics

Clinical Relevance of the Pharmacokinetic Interactions of Azole Antifungal Drugs with Other Coadministered Agents

Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions

Intervention to Improve Adherence to Lipid-Lowering Medication and Lipid-Levels in Patients With an Increased Cardiovascular Risk

Efficacy of Adding Indinavir to Previous Reverse Transcriptase Nucleoside Analogues in Relation to Genotypic and Phenotypic Resistance Development in Advanced HIV-1-Infected Patients

Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine

Drug Interactions Between Antiretroviral Drugs and Comedicated Agents

Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation

Steady-state pharmacokinetics and metabolism of voriconazole in patients

ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir

Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HIV and Recommendations for Postexposure Prophylaxis

Sexually Transmitted Infections Treatment Guidelines, 2021

Sexually Transmitted Diseases Treatment Guidelines, 2010

Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America

Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

Interventions for enhancing medication adherence

Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections

Software for Dosage Individualization of Voriconazole for Immunocompromised Patients

Polypharmacy and Medication Adherence in Patients With Type 2 Diabetes

Factors affecting therapeutic compliance: A review from the patient’s perspective

Determination of indinavir, an HIV-protease inhibitor, in human plasma by reversed-phase high-performance liquid chromatography

Effect of an Antiretroviral Regimen Containing Ritonavir Boosted Lopinavir on Intestinal and Hepatic CYP3A, CYP2D6 and P-glycoprotein in HIV-infected Patients

Pharmacokinetics and safety of 14 days intravenous voriconazole in allogeneic haematopoietic stem cell transplant recipients

The effect of fluconazole on ritonavir and saquinavir pharmacokinetics in HIV‐1‐infected individuals

Evaluation of two immunoassays for the determination of zidovudine in biological matrices.

Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study